EC LIONESS LLC – Trademark Portfolio
Entity Type: 16
EC LIONESS LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include CHIOMA. The owner is based in FARMERS BRANCH, TX.
14454 MIDWAY ROAD
FARMERS BRANCH, TX 75244
Showing of trademarks Trademarks
Trademark Classifications
EC LIONESS LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does EC LIONESS LLC have?
EC LIONESS LLC has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 cancelled.
What trademark classes does EC LIONESS LLC file in?
EC LIONESS LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 3 (Cosmetics & Cleaning), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are EC LIONESS LLC's most well-known trademarks?
EC LIONESS LLC's registered trademark portfolio includes well-known marks such as CHIOMA. These are among 3 currently registered trademarks in the portfolio.
What is EC LIONESS LLC's trademark registration success rate?
EC LIONESS LLC has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.